medigraphic.com
ISSN 1561-2945 (Print)

2023, Number 1

<< Back Next >>

Revista Cubana de Cirugía 2023; 62 (1)

Results of conservative or radical breast surgeries in patients operated on at Centro de Investigaciones Médico Quirúrgicas, Cuba

Ramírez FY, Borroto MK, Rodríguez RI, Madrigal BG

Language: Spanish
References: 19
Page:
PDF size: 317.11 Kb.


ABSTRACT

Introduction: Cancer has caused more deaths than all known wars and catastrophes. Particularly speaking, breast cancer has become a pandemic that threatens to continue to spread.
Objective: To describe the differences based on the results obtained from conservative and radical surgery as a treatment for breast cancer.
Methods: An analytical, observational, descriptive and retrospective study was carried out with a universe of 177 female patients diagnosed with breast cancer in the general surgery service of Centro de Investigaciones Médico Quirúrgicas, of La Habana, Cuba. All of them received surgical treatment in the period from January 2011 to December 2016.
Results: 92.09% of the patients studied had no history of breast pathology, while 36.72% had breast cancer as a family pathological history. Patients over 70 years of age predominated in both surgical techniques. In the group of 30-40 years of age only conservative techniques were performed. With respect to staging, there was a predominance of the disease in stage II. Overall survival at 5 years was higher than 90%, while the disease-free interval remained at similar values for both techniques.
Conclusions: A greater amount of breast-conserving surgeries were performed in patients at earlier clinical stages of the disease, while overall survival of conservative procedures was slightly higher.


REFERENCES

  1. Pardo Montañez S, Ramírez Alemán I, Selva Capdesuñer A, Cuza Palacios M. Modificación de conocimientos sobre cáncer de mama en trabajadoras con factores de riesgo de la enfermedad. MEDISAN. 2011 [acceso 15/07/2016];15(1):[aprox 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S102930192011000100013&script=sci_arttext&tlng=en1.

  2. Jing S. Decision aids on breast conserving surgery for early stage breast cancer patients: a systematic review. BMC Med Inform Decis Mak. 2020;20:275. DOI: https://doi.org/10.1186/s12911-020-01295-82.

  3. Tosello G, Torloni MR, Mota BS, Neeman T, Riera R. Breast surgery for metastatic breast cancer (Review). Cochrane Database of Systematic Reviews. 2018;3:CD011276. DOI: https://doi.org/10.1002/14651858.CD011276.pub23.

  4. Cardoso F. et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2019;30:1194-220. DOI: https://doi.org/doi:10.1093/annonc/mdz1734.

  5. Ministerio de Salud Pública. Anuario Estadístico de Salud 2020. La Habana: Dirección Nacional de Registros Médicos y Estadística de Salud; 2021 [acceso 19/12/2022]. Disponible en: Disponible en: https://files.sld.cu/bvscuba/files/2021/08/Anuario-Estadistico-Espa%c3%b1ol-2020-Definitivo.pdf 5.

  6. Hernández Durán D, Díaz Mitjans O, Abreu Vázquez MR. Un análisis de largo plazo del comportamiento de la cirugía conservadora del cáncer de mama. Revista Cubana de Ginecología y Obstetricia 2012;38(1):117-33.

  7. Sanati-Mehrizy P. A Comparison of Postoperative Outcomes in Immediate Versus Delayed Reconstruction After Mastectomy. ePlasty. 2015 [acceso 15/08/2016];30(15):e44. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594228/pdf/eplasty15e44.pdf7.

  8. Kaufman C. S. Increasing Role of Oncoplastic Surgery for Breast Cancer. Current Oncology Reports. 2019;21:111. DOI: https://doi.org/10.1007/s11912-019-0860-98.

  9. Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 2016;212:660-9. DOI: https://doi.org/10.1016/j.amjsurg.2016.06.0109.

  10. Mesdag V. Nipple sparing mastectomy for breast cancer is associated with high patient satisfaction and safe oncological outcomes. J Gynecol Obstet Hum Reprod. 2017;46:637-42. DOI: https://doi.org/10.1016/j.jogoh.2017.07.00310.

  11. Nápoles Izquierdo Y, García Novoa W, Díaz Agüero H, Báez Pupo MM. Cirugía conservadora y radical en estadios tempranos del cáncer. AMC. 2009 [acceso 15/06/2016];13(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552009000300011&lng=es11.

  12. Rizvi FH. Early postoperative outcomes of breast cancer surgery in a developing country. Cureus. 2020;12(8):e9941. DOI: https://doi.org/10.7759/cureus.994112.

  13. Luciano Stóver AC, Montejo Viamontes N, Loys Fernandez JL, Vila Garcia E. Resultados del tratamiento quirúrgico del cáncer de mama en mujeres hasta 40 años de edad. Rev Cubana Cir. 2018 [acceso 19/02/2022];57(2):1-11. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932018000200006&lng=es13.

  14. Moo TA, Sanford R, Dang C, Morrow M. Overview of Breast Cancer Therapy. PET Clin. 2018;13(3):339-54. DOI: https://doi.org/10.1016/j.cpet.2018.02.00614.

  15. Burstein HJ. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Annals of Oncology. 2019;30:1541-57. DOI: https://doi.org/10.1093/annonc/mdz23515.

  16. Mori I, Yang Q, Kakudo K. Predictive and prognosis markers for invasive breast cancer. Pathol Int. 2002;52(3):186-94. DOI: https://doi.org/10.1046/j.1440-1827.2002.01335.x16.

  17. Wishart GC. A population-based validation of the prognostic mode! PREDICT for early breast cancer. Eur J Surg Oncol. 2011;37(5):411-7. DOI: https://doi.org/10.1016.j.ejso.2011.02.00117.

  18. Ferreiro García E. Estudio Cohortes ambispectivo de supervivencia y periodo libre de enfermedad en pacientes con cáncer de mama sometidas a estimulación ovárica controlada. [Tesis Doctoral]. España: Universitat de Valéncia; 2021.

  19. Magnoni F. Breast Cancer Surgery: New Issues. Curr. Oncol. 2021:28:4053-66. DOI: https://doi.org/10.3390/curroncol2805034419.




2020     |     www.medigraphic.com